SIRNA

SIRNA

#More

SIRNA

Industry:
Biotechnology

Status:
Active


More informations about "SIRNA"

Lipid-siRNA Organization Modulates the Intracellular Dynamics of …

Mar 11, 2025 Lipid-siRNA organization was modulated by adjusting the nitrogen-to-phosphate (N/P) ratio, which reflects the molar ratio of nitrogen groups in ionizable lipids to phosphate …See details»

Lipid-siRNA Organization Modulates the Intracellular Dynamics of …

These alterations in lipid-siRNA organization affect LNP membrane fluidity, enhancing LNP fusion with cellular membranes and promoting cytosolic siRNA delivery, primarily via …See details»

Molecular Mechanisms and Biological Functions of siRNA

SiRNA therapeutics are now well poised to enter the clinical formulary as a new class of drugs in the near future. siRNA-based therapies are emerging as a promising new anticancer …See details»

A Comprehensive Review of Small Interfering RNAs (siRNAs): …

Lipophile-siRNA conjugates, in which cholesterol is coupled to the 3’ end of the siRNA sense strand via a pyrrolidone bond, not only increase the transfection efficiency of siRNA in vitro but also enhance the pharmacokinetics of siRNA in vivo. 187 In 2007, Wolfrum et al investigated the use of high-density lipoprotein (HDL) to further optimize cholesterol-siRNA conjugates, …See details»

Strategies, Design, and Chemistry in siRNA …

A. An illustration of RNA interference process 3. b. Strategies and procedures for siRNA development and delivery. Delivery of siRNA has been the major challenge to application of siRNA …See details»

siRNA Seed Region Is Divided into Two Functionally Different …

Jan 4, 2022 In RNA interference (RNAi), small interfering RNA (siRNA) functions to suppress the expression of its target mRNA with perfect sequence complementarity. In a mechanism different from above, siRNA also suppresses unintended mRNAs with partial sequence complementarities, mainly to the siRNA seed region (nucleotides 2–8). This mechanism is largely utilized by …See details»

siRNA (Small Interfering RNA): Structure …

Sep 4, 2019 Structurally, it is a dsRNA and shorter in length with an overhang at one end. From the double-strand, one strand is known as a guided strand while the other is known as a …See details»

Improving siRNA Delivery In Vivo Through Lipid Conjugation

Impact of siRNA chemical architecture on lipid conjugate-mediated delivery. Although cholesterol conjugation broadly promotes cellular internalization, the nucleic acid modifications also …See details»

siRNA: Mechanism of action, challenges, and therapeutic approaches

Aug 15, 2021 The mechanism of action of small interfering RNA (siRNA) is based on post-transcriptional gene silencing. siRNA molecules are usually specific and efficient in the knockdown of disease-related genes. However, they are characterized by low cellular uptake and are susceptible to nuclease-mediated degradation. Therefore, siRNAs require a carrier ...See details»

Lipid-siRNA Organization Modulates the Intracellular

Download Citation | On Mar 11, 2025, Yulin Mo and others published Lipid-siRNA Organization Modulates the Intracellular Dynamics of Lipid Nanoparticles | Find, read and cite all the research you ...See details»

siRNA and shRNA: Mechanisms and Applications …

"siRNA can be a potent tool for selectively silencing genes, making it invaluable in both research and therapeutic settings." Design Principles for Effective siRNA. Designing effective siRNA requires careful consideration of several factors: …See details»

Lipid nanoparticle delivery systems for siRNA-based therapeutics

Therapeutics based on small interfering RNA (siRNA) have a huge potential for the treatment of disease but requires sophisticated delivery systems for in vivo applications. Lipid nanoparticles …See details»

Small Interfering RNA - an overview | ScienceDirect Topics

Small Interfering RNAs (siRNA), as Therapeutic Agents. Small interfering RNA (siRNA), also known as short interfering RNA or silencing RNA, is a class of double-stranded RNA molecules (20–25 bp length) and interferes with the expression of specific genes with complementary nucleotide sequences. RNAi has been a promising therapeutic approach ...See details»

Cohesin and condensin regulate chromosome topology and play …

1 day ago Cohesin and condensin, two related protein complexes, play essential roles in ensuring the accurate segregation of the genome into daughter cells during cell division. …See details»

What is siRNA and siRNA-seq - CD Genomics

Mechanism of siRNA Function Processing of siRNA by Dicer . Dicer Structure and Function: The journey of siRNA begins with its processing from long double-stranded RNA (dsRNA) into shorter siRNA molecules by the enzyme Dicer. Dicer is a member of the RNase III family and has distinct domains that include a helicase domain, a PAZ (Piwi/Argonaute/Zwille) domain, two RNase III …See details»

Inhibition of sphingomyelin synthase (SMS) affects intracellular ...

Cells were then pulsed with [14C]-L-serine (a precursor of all sphingolipids). SMS activity and [14C]-SM in the cells were monitored. We found that SMS activity was significantly decreased …See details»

siRNA modification and delivery for drug development

Aug 28, 2022 Five siRNA therapeutics (Onpattro i, Givlaari ii, Oxlumo iii, Leqvio iv, and Amvuttra v) have been approved by the FDA and European Medicines Agency (EMA) by using LNP and …See details»

Clinical advances of siRNA therapeutics - Hu - 2019 - The Journal …

May 9, 2019 Small interfering RNA (siRNA) enables efficient target gene silencing by employing a RNA interference (RNAi) mechanism, which can compromise gene expression and regulate …See details»

Where should siRNAs go: applicable organs for siRNA drugs

Jul 10, 2023 A divalent siRNA (di-siRNA), in which two siRNAs are chemically conjugated, contains enough phosphorothioates in its backbone to help cellular uptake and promote a broad distribution 83. siRNA ...See details»

Therapeutic siRNA: state of the art - PMC - PubMed Central (PMC)

Furthermore, investigators from Alnylam have disclosed that the hepatotoxicity of GalNAc (N-acetylgalactosamine)-siRNA conjugates is attributed to off-target gene silencing mediated by …See details»